RTI Biologics, Inc. (RTIX) Tops Q4 EPS by 1c; Issues Light FY12 Outlook, Guides Q1
Tweet
Share
E-mailGet Alerts RTIX Hot Sheet
Price: $3.14 --0%
Financial Fact:
Total other expense - net: -374K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total other expense - net: -374K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
RTI Biologics, Inc. (NASDAQ: RTIX) reported Q4 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $42.9 million versus the consensus estimate of $41.24 million.
RTI Biologics, Inc. sees FY2012 EPS of $0.15-$0.17, versus the consensus of $0.18. RTI Biologics, Inc. sees FY2012 revenue of $174-$176 million, versus the consensus of $175.84 million.
RTI Biologics, Inc. sees Q1 2012 EPS of $0.03, versus the consensus of $0.04. RTI Biologics, Inc. sees Q1 2012 revenue of $41-$42 million, versus the consensus of $42.46 million.
For earnings history and earnings-related data on RTI Biologics, Inc. (RTIX) click here.
RTI Biologics, Inc. sees FY2012 EPS of $0.15-$0.17, versus the consensus of $0.18. RTI Biologics, Inc. sees FY2012 revenue of $174-$176 million, versus the consensus of $175.84 million.
RTI Biologics, Inc. sees Q1 2012 EPS of $0.03, versus the consensus of $0.04. RTI Biologics, Inc. sees Q1 2012 revenue of $41-$42 million, versus the consensus of $42.46 million.
For earnings history and earnings-related data on RTI Biologics, Inc. (RTIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Reading (RDI) Tops Q2 EPS by 4c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
